Encephalopathy after High-Dose Ifosfamide: A Retrospective Cohort Study and Review of the Literature

Background: Encephalopathy occurs in 10–40% of patients treated with high-dose ifosfamide. Proposed risk factors for encephalopathy include hepatic or renal dysfunction, brain metastases, electrolyte imbalances and drug-drug interactions. Objective: The purpose of this retrospective cohort study and...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Drug safety 2008-01, Vol.31 (11), p.989-996
Hauptverfasser:	Sweiss, Karen I., Beri, Rakesh, Shord, Stacy S.
Format:	Artikel
Sprache:	eng
Schlagworte:	Adult Albumins - metabolism Antineoplastic Agents, Alkylating - administration & dosage Antineoplastic Agents, Alkylating - adverse effects Antineoplastic Agents, Alkylating - therapeutic use Bilirubin - blood Biological and medical sciences Brain Diseases - chemically induced Brain Diseases - drug therapy Brain Diseases - epidemiology Cohort Studies Complications and side effects Drug Safety and Pharmacovigilance Drug therapy Drug toxicity and drugs side effects treatment Encephalopathy Enzyme Inhibitors - therapeutic use Female Hemoglobins - metabolism Humans Ifosfamide Ifosfamide - administration & dosage Ifosfamide - adverse effects Ifosfamide - therapeutic use Male Medical sciences Medicine Medicine & Public Health Methylene Blue - therapeutic use Middle Aged Nervous System Diseases - chemically induced Nervous System Diseases - epidemiology Obesity - complications Obesity - epidemiology Pharmacology. Drug treatments Pharmacology/Toxicology Retrospective Studies Risk Factors Sarcoma - complications Sarcoma - drug therapy Sarcoma - pathology Sex Factors Short Communication Toxicity: nervous system and muscle Tumors
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!